Exchange: NASDAQ·Updated 07:30 PM EDT

APGE News

News
all
press releases
ABBV Stock Trading Above 50- & 200-Day SMAs: Buy, Hold or Sell?
AbbVie's Skyrizi, Rinvoq and neuroscience drugs drive growth, but Humira erosion, oncology and Aesthetics remain key headwinds.
Zacks
More News
AbbVie Completes Acquisition of Apogee Therapeutics
AbbVie Completes Acquisition of Apogee Therapeutics AbbVie Completes Acquisition of Apogee Therapeutics PR Newswire NORTH CHICAGO, Ill., Sept. 3, 2026 Acquisition deepens AbbVie's robust immunology pipeline with diverse assets targeting dermatologic, respiratory and other inflammatory and...
PR Newswire
ABBV Stock Dips 4% Despite Robust Q2: Buy the Dip or Stay Cautious?
ABBV falls after cutting its 2026 EPS outlook to reflect the Apogee deal, despite strong Q2 results, higher revenue guidance and growth from key medicines.
Zacks
Are DSGR, AVB, SLP, APGE Obtaining Fair Deals for their Shareholders?
Are DSGR, AVB, SLP, APGE Obtaining Fair Deals for their Shareholders? Are DSGR, AVB, SLP, APGE Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, July 31, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed...
PR Newswire
Is Apogee Therapeutics Inc. (APGE) Stock Outpacing Its Medical Peers This Year?
Here is how Apogee Therapeutics Inc. (APGE) and Iovance Biotherapeutics (IOVA) have performed compared to their sector so far this year.
Zacks
Should You Buy, Sell or Hold ABBV Stock After Its 9% YTD Rise?
ABBV stock rallies 9% YTD as Skyrizi and Rinvoq offset Humira declines, but can its pipeline, neuroscience growth and Apogee deal sustain long-term momentum?
Zacks
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--CRBG, RMAX, GBCS, and APGE
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--CRBG, RMAX, GBCS, and APGE $HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--CRBG, RMAX, GBCS, and APGE PR Newswire NEW YORK, July 14, 2026 NEW YORK, July 14, 2026 /PRNewswire...
PR Newswire
Are AVB, LPRO, APGE, TMHC Obtaining Fair Deals for their Shareholders?
Are AVB, LPRO, APGE, TMHC Obtaining Fair Deals for their Shareholders? Are AVB, LPRO, APGE, TMHC Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, July 6, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed...
PR Newswire
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--AVB, APGE, TMHC, and LPRO
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--AVB, APGE, TMHC, and LPRO $HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--AVB, APGE, TMHC, and LPRO PR Newswire NEW YORK, July 6, 2026 NEW YORK, July 6, 2026 /PRNewswire/ -- Class...
PR Newswire
Are APGE, INVE, CBAN, FSRL Obtaining Fair Deals for their Shareholders?
Are APGE, INVE, CBAN, FSRL Obtaining Fair Deals for their Shareholders? Are APGE, INVE, CBAN, FSRL Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, July 2, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed...
PR Newswire

Advertisement|Remove ads.